Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of IPX203 in Parkinson's Disease Participants With Motor Fluctuations [Phase 3]

View source ↗

Summary

Phase 3 study evaluating IPX203 for Parkinson's disease with motor fluctuations has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• IPX203

Snippet

Sponsor: Impax Laboratories, LLC | Conditions: Parkinson's Disease (Disorder) | Phase 3 | Status: COMPLETED | Results posted: 2023-02-09